StayHappi Glucosamine+Diacerein+Methyl Sulfonyl Methane 750mg/50mg/250mg Tablet
By StayHappi
Rx
10 Tablet in a Strip

Composition
Glucosamine(750mg) + Diacerein(50mg) + Methyl Sulfonyl Methane(250mg)

Manufacturer - Sarvagunaushdhi Pvt Ltd
13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN

Expires on or after
August, 2025

liver
Caution should be exercised when using StayHappi Glucosamine+Diacerein+Methyl Sulfonyl Methane 750mg/50mg/250mg Tablet in individuals with liver disease as it is considered unsafe. It is advisable to avoid using this medication if you have liver issues. Please seek advice from your doctor regarding the use of StayHappi Glucosamine+Diacerein+Methyl Sulfonyl Methane 750mg/50mg/250mg Tablet if you have liver disease.

kidney
StayHappi Glucosamine+Diacerein+Methyl Sulfonyl Methane 750mg/50mg/250mg Tablet is likely safe for use in patients with kidney disease. Limited data suggests no dose adjustment may be necessary. Consult your doctor for guidance.

alcohol
When taking StayHappi Glucosamine+Diacerein+Methyl Sulfonyl Methane 750mg/50mg/250mg Tablet, it is important to be cautious when drinking alcohol. It is recommended to consult your doctor for advice on alcohol consumption.

driving
It is not known if StayHappi Glucosamine+Diacerein+Methyl Sulfonyl Methane 750mg/50mg/250mg Tablet affects driving ability. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
It is better to consult your doctor before using StayHappi Glucosamine+Diacerein+Methyl Sulfonyl Methane 750mg/50mg/250mg Tablet during pregnancy.

breastfeeding
"Consult your doctor regarding the safety of using StayHappi Glucosamine+Diacerein+Methyl Sulfonyl Methane 750mg/50mg/250mg Tablet while breastfeeding."
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹70
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024